Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Brad Glick DO, MPH, FAAD

Brad P. Glick DO, MPH, FAAD

Program Director, Dermatology Residency, Larkin Community Hospital, Palm Springs Campus, Miami, Florida

Dr. Brad Glick is a board-certified dermatologist practicing at the Glick Skin Institute in Margate and Wellington, Florida. He is also an Assistant Clinical Professor of Dermatology at Herbert Wertheim College of Medicine at Florida International University and Dermatology Residency Program Director at the Larkin Palm Springs Hospital, Miami, Florida.

Dr. Glick is the Past President of the Florida Academy of Dermatology, a member of the Board of Directors of the American Academy of Dermatology, and a member of the Medical Board of the National Psoriasis Foundation.

Disclosures

Dr. Glick reports the following:

  • AbbVie - I,A,S
  • AstraZeneca - I
  • Amgen - I,A,S
  • Janssen - S
  • Galderma - I,A
  • Sun Pharma - I,A,S
  • Leo Pharma - A
  • Lilly - I,A,S
  • Novartis - A,S
  • Dermavant Sciences - A,I,S
  • Incyte- A,S
  • BMS - A,I,S
  • Nimbus Lakshmi, Inc - I
  • Cara Therapeutics - I
  • Dermira: I,A,S
  • Sanofi/Genzyme: A,S
  • Regeneron - S
  • Pfizer - A,S
  • ChemoCentryx - I
  • Ortho Dermatologics - A,S
  • UCB - A,S
  • Brickell Biotech - I
  • CorEvitas Registry PSO - I
  • CorEvitas Registry AD - I
  • PROSE Registry for AD - I
  • Stock Holder: Top MD